Bristol-Myers Squibb BMY Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's operating cash flow?
- Bristol-Myers Squibb (BMY) reported operating cash flow of $1.1B in Q1 2026.
- How has Bristol-Myers Squibb's operating cash flow changed year-over-year?
- Bristol-Myers Squibb's operating cash flow decreased by 43.5% year-over-year, from $1.95B to $1.1B.
- What is the long-term trend for Bristol-Myers Squibb's operating cash flow?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's operating cash flow has grown at a -3.3% compound annual growth rate (CAGR), from $16.21B to $14.16B.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.